Last Chance to View: How RWD Can Transform The Patient Journey [From our Partner]

The webinar includes executives from PurpleLab and Dr. Ben Freiberg, Principal Informatics Systems Lead with Genentech's gCS Computational Catalysts. Genentech is owned by Roche.

View in browser Eliminating Blind Spots in the Patient Journey Understanding the patient journey—from diagnosis through treatment—is crucial for drug developers aiming to create more effective therapies. Using non small cell lung cancer (NSCLC) as an example, PurpleLab and Genentech will explore how to leverage Real World Data to eliminate blind spots in the patient journey, informing every phase of a drug's lifecycle, from clinical development to market access.    This on-demand webinar will also highlight the following: Mapping the nuanced parts of a patient's journey The value of leveraging Social Determinants of Health data Addressing socioeconomic barriers that may hinder clinical trial participation Using RWD to improve clinical trial recruitment, clinical endpoints, and inform market access strategies Watch Now MedCity News, PO Box 901, New York, NY 10272, United States, 2123341871 Unsubscribe Manage preferences